Maternal and Child Outcomes Reported by Breastfeeding Women Following Messenger RNA COVID-19 Vaccination
Kerri Bertrand, Gordon Honerkamp‐Smith, Christina Chambers
Abstract
Background: In December 2020, two novel messenger RNA (mRNA) vaccines for severe acute respiratory syndrome coronavirus-2 received emergency use authorization from the U.S. Food and Drug Administration; however, the early trials excluded lactating women.
Topics & Concepts
MedicineBreastfeedingVaccinationAdverse effectBreast milkPediatricsInternal medicineImmunologyChemistryBiochemistryCOVID-19 Impact on ReproductionVaccine Coverage and HesitancyReproductive System and Pregnancy